For licensed medical professionals and compounding pharmacies only. Not for sale to the general public.  ·  787-822-8197
Build Your Order Apply for Wholesale
Build Your Order Products For Clinics For Pharmacies For Brands Quality Wholesale Resources About Contact Apply for Wholesale
Product sourcing reference

Thymosin Alpha-1 Sourcing Review

Thymosin alpha-1 requires its own identity and regulatory assessment. Do not group it with other thymosin peptides or assume an international product establishes U.S. availability.

Reference variants

Add Thymosin Alpha-1 to an order request

Quantities are individual vials (packs of 10). Orders need 100 vials and/or 20 spray bottles in total, mixed across items. Prices are reference estimates captured 2026-10-16; every request is pending eligibility and availability review. Per-unit figures are rounded to the cent from kit pricing, so a final quote may differ slightly.

  • 10mgVial · confirm physical formCAS 62304-98-7
    $27.31/vial$21.85/vial at 1,000+ vials of this item
    vials, packs of 10

Review your order request · Compare the full catalog

Distinguish alpha-1 from beta-family peptides

Use the full substance name and sequence in purchasing records. Similar thymosin names are not evidence of interchangeability or a shared clinical purpose.

Separate foreign authorization from U.S. eligibility

If a proposal references a product marketed abroad, record the exact product and jurisdiction. Foreign marketing status does not establish a lawful U.S. distribution or compounding route.

Before a sourcing inquiry

For Thymosin Alpha-1, provide the exact substance or finished-product identity, intended transaction, facility type and destination state. Do not send patient information. A qualified reviewer must confirm the applicable pathway before purchasing.

  • Obtain product- and lot-specific identity and quality records before accepting material.
  • Verify storage, shipping and dating against the actual preparation, not a generic catalog range.
  • Request written confirmation of availability and terms; this page does not confirm stock, strength, price or supply eligibility.

We do not currently have verified COAs available to publish. No purity, sterility or lot-release result is established by this page.

Purchasing questions

Can another thymosin product substitute for alpha-1?

No automatic substitution is appropriate. Identity, formulation, evidence and regulatory status must be independently reviewed by the responsible clinical and pharmacy professionals.

Related sourcing guidance

Keep alpha-1 separate from beta-4 references

FDA notes inadequate safety-related information for proposed compounded thymosin-alpha-1 products. Its name should not be shortened to thymosin when that could confuse it with TB-500 or another substance.

Documentation to request

Require the full substance name and sequence-matched identity documentation. Do not use a beta-4 report to qualify an alpha-1 item.

Regulatory context: FDA: substance-specific safety concerns. Source reviewed . This source does not verify the identity, testing or availability of our catalog references.

Related guidance: Evidence review before expanding a clinic menu. These references support a review, not a treatment recommendation or supply authorization.

Verify the current regulatory position

Use FDA human drug compounding guidance and applicable state requirements. A compounded preparation is not FDA-approved. This reference is not medical or legal advice and does not establish a lawful supply route.

Ask about the review requirements

Ask what information is needed to assess a Thymosin Alpha-1 inquiry. An inquiry is not confirmation that the product can be supplied.

Discuss sourcing requirements
Call Apply for Wholesale